{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:33:37Z","timestamp":1762673617239},"reference-count":80,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.antiviral.2007.03.001","type":"journal-article","created":{"date-parts":[[2007,3,27]],"date-time":"2007-03-27T11:16:30Z","timestamp":1174994190000},"page":"93-103","source":"Crossref","is-referenced-by-count":10,"title":["Insertions in the \u03b23\u2013\u03b24 loop of reverse transcriptase of human immunodeficiency virus type 1 and their mechanism of action, influence on drug susceptibility and viral replication capacity"],"prefix":"10.1016","volume":"75","author":[{"given":"Dirk","family":"Eggink","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marleen C.D.G.","family":"Huigen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.B.","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"G\u00f6tte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"Nijhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2007.03.001_bib1","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1128\/JVI.66.9.5627-5630.1992","article-title":"Persistence of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera","volume":"66","author":"Albert","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00042560-200201010-00015","article-title":"Multidrug-resistant HIV-1 RNA and proviral DNA variants harboring new dipeptide insertions in the reverse transcriptase pol gene","volume":"29","author":"Andreoletti","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.antiviral.2007.03.001_bib3","doi-asserted-by":"crossref","first-page":"15908","DOI":"10.1021\/bi981200e","article-title":"Phenotypic mechanism of HIV-1 resistance to 3\u2032-azido-3\u2032-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase","volume":"37","author":"Arion","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2007.03.001_bib4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00126334-200007010-00007","article-title":"Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1-infected Italian patients with virologic failure","volume":"24","author":"Balotta","year":"2000","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.antiviral.2007.03.001_bib5","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1128\/AAC.37.10.2231","article-title":"High-level resistance to (\u2212) enantiomeric 2\u2032-deoxy-3\u2032-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase","volume":"37","author":"Boucher","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.03.001_bib6","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1128\/AAC.37.7.1525","article-title":"Effects of discontinuation of zidovudine treatment on zidovudine sensitivity of human immunodeficiency virus type 1 isolates","volume":"37","author":"Boucher","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.03.001_bib7","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1006\/jmbi.1998.2508","article-title":"Analysis of amino insertion mutations in the fingers subdomain of HIV-1 reverse transcriptase","volume":"286","author":"Boyer","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib8","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1128\/JVI.75.10.4832-4842.2001","article-title":"Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase","volume":"75","author":"Boyer","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib9","doi-asserted-by":"crossref","first-page":"9143","DOI":"10.1128\/JVI.76.18.9143-9151.2002","article-title":"Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision","volume":"76","author":"Boyer","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000050068","article-title":"Prevalence and genetic heterogeneity of the reverse transcriptase T69S-S-X insertion in pretreated HIV-infected patients","volume":"44","author":"Briones","year":"2001","journal-title":"Intervirology"},{"key":"10.1016\/j.antiviral.2007.03.001_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/135965359900400211","article-title":"Different outcome in the first two patients with an HIV-1 multinucleoside drug-resistant T69SSS insertion in Spain","volume":"4","author":"Briones","year":"1999","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2007.03.001_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1386-6532(03)00082-9","article-title":"Unusual codon 69 insertions: influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility","volume":"29","author":"Bulgheroni","year":"2004","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jmb.2006.09.073","article-title":"Mutational patterns associated with the 69 insertion complex in multi-drug-resistant HIV-1 reverse transcriptase that confer increased excision activity and high-level resistance to zidovudine","volume":"365","author":"Cases-Gonzalez","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib14","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1086\/516511","article-title":"Mutations in the pol gene of human immunodeficiency virus type 1 in infected patients receiving didanosine and hydroxyurea combination therapy","volume":"176","author":"De Antoni","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.03.001_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/aid.1992.8.119","article-title":"HIV inhibitors targeted at the reverse transcriptase","volume":"8","author":"De Clercq","year":"1992","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.antiviral.2007.03.001_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00002030-199901140-00010","article-title":"Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs","volume":"13","author":"de Jong","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2007.03.001_bib17","doi-asserted-by":"crossref","first-page":"42097","DOI":"10.1074\/jbc.M206725200","article-title":"The molecular mechanism of multidrug resistance by the Q151M human immunodeficiency virus type 1 reverse transcriptase and its suppression using alpha-boranophosphate nucleotide analogues","volume":"277","author":"Deval","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2007.03.001_bib18","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1006\/jmbi.1998.2208","article-title":"Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution","volume":"284","author":"Ding","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib19","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1128\/AAC.37.6.1390","article-title":"The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2\u2032,3\u2032-dideoxyinosine and 2\u2032,3\u2032-dideoxycytidine confers high-level resistance to the (\u2212) enantiomer of 2\u2032,3\u2032-dideoxy-3\u2032-thiacytidine","volume":"37","author":"Gao","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.03.001_bib20","first-page":"210","article-title":"Clinical implications of HIV drug resistance to nucleoside and nucleotide reverse transcriptase inhibitors","volume":"8","author":"Geretti","year":"2006","journal-title":"AIDS Rev."},{"key":"10.1016\/j.antiviral.2007.03.001_bib21","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.biocel.2004.02.028","article-title":"Primer unblocking by HIV-1 reverse transcriptase and resistance to nucleoside RT inhibitors (NRTIs)","volume":"36","author":"Goldschmidt","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1586\/14789072.2.5.707","article-title":"Inhibition of HIV-1 reverse transcription: basic principles of drug action and resistance","volume":"2","author":"Gotte","year":"2004","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"10.1016\/j.antiviral.2007.03.001_bib23","doi-asserted-by":"crossref","first-page":"7128","DOI":"10.1128\/JVI.66.12.7128-7135.1992","article-title":"Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2\u2032,3\u2032-dideoxyinosine and 2\u2032,3\u2032-dideoxycytidine","volume":"66","author":"Gu","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib24","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1093\/nar\/26.14.3433","article-title":"Pausing of reverse transcriptase on retroviral RNA templates is influenced by secondary structures both 5\u2032 and 3\u2032 of the catalytic site","volume":"26","author":"Harrison","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2007.03.001_bib25","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.1128\/JVI.70.11.8010-8018.1996","article-title":"An in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3\u2032-azido-3\u2032-deoxythymidine","volume":"70","author":"Hooker","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib26","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1126\/science.282.5394.1669","article-title":"Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance","volume":"282","author":"Huang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2007.03.001_bib27","series-title":"Proceedings of the Third European HIV Drug Resistance Workshop","first-page":"45","article-title":"Evolution of a novel 5 amino acid insertion in HIV-1 RT towards a replication competent high-level drug-resistant insertion variant","author":"Huigen","year":"2005"},{"key":"10.1016\/j.antiviral.2007.03.001_bib28","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1128\/JVI.70.2.1086-1090.1996","article-title":"Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy","volume":"70","author":"Iversen","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib29","doi-asserted-by":"crossref","first-page":"10895","DOI":"10.1073\/pnas.88.23.10895","article-title":"Crystals of a ternary complex of human immunodeficiency virus type 1 reverse transcriptase with a monoclonal antibody Fab fragment and double-stranded DNA diffract x-rays to 3.5-A resolution","volume":"88","author":"Jacobo-Molina","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2007.03.001_bib30","first-page":"125","article-title":"Update of the drug resistance mutations in HIV-1: fall 2006","volume":"14","author":"Johnson","year":"2006","journal-title":"Top. HIV Med."},{"key":"10.1016\/j.antiviral.2007.03.001_bib31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0165-2478(00)00209-1","article-title":"Emergence of HIV-1 variants containing codon insertions and deletions in the beta3\u2013beta4 hairpin loop domain of reverse transcriptase","volume":"74","author":"Kaliki","year":"2000","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.antiviral.2007.03.001_bib32","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1021\/bi991376w","article-title":"Role of glutamine 151 of human immunodeficiency virus type-1 reverse transcriptase in substrate selection as assessed by site-directed mutagenesis","volume":"39","author":"Kaushik","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2007.03.001_bib33","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1073\/pnas.89.5.1934","article-title":"Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine","volume":"89","author":"Kellam","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2007.03.001_bib34","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1128\/JVI.71.4.3346-3350.1997","article-title":"Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase","volume":"71","author":"Keulen","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib35","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1074\/jbc.273.13.7529","article-title":"Insertions into the beta3\u2013beta4 hairpin loop of HIV-1 reverse transcriptase reveal a role for fingers subdomain in processive polymerization","volume":"273","author":"Kew","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2007.03.001_bib36","doi-asserted-by":"crossref","first-page":"11227","DOI":"10.1128\/JVI.75.22.11227-11233.2001","article-title":"Functional correlates of insertion mutations in the protease gene of human immunodeficiency virus type 1 isolates from patients","volume":"75","author":"Kim","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib37","doi-asserted-by":"crossref","first-page":"10292","DOI":"10.1021\/bi970512z","article-title":"Single-step kinetics of HIV-1 reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3-TC","volume":"36","author":"Krebs","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2007.03.001_bib38","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/AAC.43.8.1961","article-title":"A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance","volume":"43","author":"Larder","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.03.001_bib39","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1126\/science.2467383","article-title":"HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy","volume":"243","author":"Larder","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2007.03.001_bib40","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/088922202760072375","article-title":"Genotypic and phenotypic analysis of a novel 15-base insertion occurring between codons 69 and 70 of HIV type 1 reverse transcriptase","volume":"18","author":"Lobato","year":"2002","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.antiviral.2007.03.001_bib41","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/088922201750252007","article-title":"Selection by AZT and rapid replacement in the absence of drugs of HIV type 1 resistant to multiple nucleoside analogs","volume":"17","author":"Lukashov","year":"2001","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.antiviral.2007.03.001_bib42","doi-asserted-by":"crossref","first-page":"35362","DOI":"10.1074\/jbc.M304262200","article-title":"Site-specific footprinting reveals differences in the translocation status of HIV-1 reverse transcriptase. Implications for polymerase translocation and drug resistance","volume":"278","author":"Marchand","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2007.03.001_bib43","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.biocel.2004.02.029","article-title":"Impact of the translocational equilibrium of HIV-1 reverse transcriptase on the efficiency of mismatch extensions and the excision of mispaired nucleotides","volume":"36","author":"Marchand","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib44","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1093\/emboj\/19.21.5752","article-title":"Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance","volume":"19","author":"Mas","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2007.03.001_bib45","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-2836(02)00911-7","article-title":"Multidrug-resistant HIV-1 reverse transcriptase: involvement of ribonucleotide-dependent phosphorolysis in cross-resistance to nucleoside analogue inhibitors","volume":"323","author":"Mas","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib46","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1128\/AAC.45.6.1836-1842.2001","article-title":"Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors","volume":"45","author":"Masquelier","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.03.001_bib47","doi-asserted-by":"crossref","first-page":"24569","DOI":"10.1074\/jbc.M312658200","volume":"279","author":"Matamoros","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2007.03.001_bib48","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1128\/JVI.77.6.3871-3877.2003","article-title":"Effects of dipeptide insertions between codons 69 and 70 of human immunodeficiency virus type 1 reverse transcriptase on primer unblocking, deoxynucleoside triphosphate inhibition, and DNA chain elongation","volume":"77","author":"Meyer","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1097-2765(00)80185-9","article-title":"A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase","volume":"4","author":"Meyer","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.antiviral.2007.03.001_bib50","doi-asserted-by":"crossref","first-page":"13471","DOI":"10.1073\/pnas.95.23.13471","article-title":"Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism","volume":"95","author":"Meyer","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2007.03.001_bib51","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1128\/AAC.46.5.1540-1545.2002","article-title":"Effects of specific zidovudine resistance mutations and substrate structure on nucleotide-dependent primer unblocking by human immunodeficiency virus type 1 reverse transcriptase","volume":"46","author":"Meyer","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl. 3","key":"10.1016\/j.antiviral.2007.03.001_bib52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/135965350100603S03","article-title":"Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure","volume":"6","author":"Miller","year":"2001","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2007.03.001_bib53","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1097\/00002030-200006160-00037","article-title":"Frequency of multinucleoside analogue-resistant genotypes observed during antiretroviral therapy","volume":"14","author":"Moyle","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2007.03.001_bib54","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1021\/bi00016a006","article-title":"Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase","volume":"34","author":"Patel","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2007.03.001_bib55","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.virol.2004.06.006","article-title":"Relative replication fitness of multi-nucleoside analogue-resistant HIV-1 strains bearing a dipeptide insertion in the fingers subdomain of the reverse transcriptase and mutations at codons 67 and 215","volume":"326","author":"Prado","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2007.03.001_bib56","doi-asserted-by":"crossref","first-page":"9222","DOI":"10.1128\/JVI.74.19.9222-9233.2000","article-title":"A dual infection\/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression","volume":"74","author":"Quinones-Mateu","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib57","doi-asserted-by":"crossref","first-page":"10546","DOI":"10.1128\/JVI.76.20.10546-10552.2002","article-title":"Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation","volume":"76","author":"Quinones-Mateu","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib58","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00126334-199910010-00005","article-title":"A novel genotype encoding a single amino acid insertion and five other substitutions between residues 64 and 74 of the HIV-1 reverse transcriptase confers high-level cross-resistance to nucleoside reverse transcriptase inhibitors","volume":"22","author":"Rakik","year":"1999","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.antiviral.2007.03.001_bib59","first-page":"290","article-title":"The reverse transcriptase codon 69 insertion is observed in nucleoside reverse transcriptase inhibitor-experienced HIV-1-infected individuals, including those without prior or concurrent zidovudine therapy","volume":"2","author":"Ross","year":"1999","journal-title":"J. Hum. Virol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib60","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00126334-200101010-00005","article-title":"Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-infected patients with failure of highly active antiretroviral therapy","volume":"26","author":"Rousseau","year":"2001","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.antiviral.2007.03.001_bib61","doi-asserted-by":"crossref","first-page":"16280","DOI":"10.1074\/jbc.M212911200","article-title":"Trapping HIV-1 reverse transcriptase before and after translocation on DNA","volume":"278","author":"Sarafianos","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2007.03.001_bib62","doi-asserted-by":"crossref","first-page":"10027","DOI":"10.1073\/pnas.96.18.10027","article-title":"Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids","volume":"96","author":"Sarafianos","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2007.03.001_bib63","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1128\/JVI.75.12.5604-5613.2001","article-title":"Augmentation of human immunodeficiency virus type 1 subtype E (CRF01_AE) multiple-drug resistance by insertion of a foreign 11-amino-acid fragment into the reverse transcriptase","volume":"75","author":"Sato","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib64","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1198-743x.2003.00864.x","article-title":"Peptide insertions in reverse transcriptase pol gene of human immunodeficiency virus type 1 as a rare cause of persistent antiretroviral therapeutic failure","volume":"10","author":"Schneider","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.antiviral.2007.03.001_bib65","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/135965350300800209","article-title":"Nucleotide analogue binding, catalysis and primer unblocking in the mechanisms of HIV-1 reverse transcriptase-mediated resistance to nucleoside analogues","volume":"8","author":"Selmi","year":"2003","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2007.03.001_bib66","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1073\/pnas.92.6.2398","article-title":"Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides","volume":"92","author":"Shirasaka","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"Suppl. 3","key":"10.1016\/j.antiviral.2007.03.001_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/135965350100603S01","article-title":"An introduction to nucleoside and nucleotide analogues","volume":"6","author":"Squires","year":"2001","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2007.03.001_bib68","doi-asserted-by":"crossref","first-page":"17395","DOI":"10.1074\/jbc.274.25.17395","article-title":"DNA polymerases: structural diversity and common mechanisms","volume":"274","author":"Steitz","year":"1999","journal-title":"J Biol Chem."},{"key":"10.1016\/j.antiviral.2007.03.001_bib69","first-page":"146","article-title":"Identification of insertion mutations in HIV-1 reverse transcriptase causing multiple drug resistance to nucleoside analogue reverse transcriptase inhibitors","volume":"2","author":"Sugiura","year":"1999","journal-title":"J. Hum. Virol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib70","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1128\/AAC.48.11.4493-4494.2004","article-title":"Uncommon association of T69 3-base-pair insertion plus Q151M multidrug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase","volume":"48","author":"Tamalet","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.03.001_bib71","doi-asserted-by":"crossref","first-page":"F161","DOI":"10.1097\/00002030-199814000-00003","article-title":"Stable rearrangements of the beta3\u2013beta4 hairpin loop of HIV-1 reverse transcriptase in plasma viruses from patients receiving combination therapy","volume":"12","author":"Tamalet","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2007.03.001_bib72","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1006\/viro.2000.0261","article-title":"Multidrug resistance genotypes (insertions in the beta3\u2013beta4 finger subdomain and MDR mutations) of HIV-1 reverse transcriptase from extensively treated patients: incidence and association with other resistance mutations","volume":"270","author":"Tamalet","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2007.03.001_bib73","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1073\/pnas.90.15.6900","article-title":"Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation","volume":"90","author":"Temin","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2007.03.001_bib74","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.1073\/pnas.90.12.5653","article-title":"Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3\u2032-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase","volume":"90","author":"Tisdale","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2007.03.001_bib75","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1021\/bi962410z","article-title":"Nucleotide-induced stable complex formation by HIV-1 reverse transcriptase","volume":"36","author":"Tong","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2007.03.001_bib76","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1128\/JVI.79.6.3536-3543.2005","article-title":"Increased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-acid insert in the reverse transcriptase","volume":"79","author":"van der Hoek","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.03.001_bib77","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/AAC.44.8.2109-2117.2000","article-title":"Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues","volume":"44","author":"Van Vaerenbergh","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.03.001_bib78","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/AAC.48.3.992-1003.2004","article-title":"Molecular mechanisms of tenofovir resistance conferred by human immunodeficiency virus type 1 reverse transcriptase containing a diserine insertion after residue 69 and multiple thymidine analog-associated mutations","volume":"48","author":"White","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.03.001_bib79","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1172\/JCI4948","article-title":"A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors","volume":"102","author":"Winters","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2007.03.001_bib80","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1097\/00002030-200012220-00019","article-title":"Evolution of HIV-1 multidrug-resistant genotypes during combination therapy and after the cessation of antiretroviral drugs","volume":"14","author":"Yahi","year":"2000","journal-title":"AIDS"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354207002355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354207002355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T05:34:58Z","timestamp":1683783298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354207002355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0166354207002355"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2007.03.001","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}